Drug Shortage Report for TEVA-VALSARTAN
Report ID | 137936 |
Drug Identification Number | 02356678 |
Brand name | TEVA-VALSARTAN |
Common or Proper name | VALSARTAN 160MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VALSARTAN |
Strength(s) | 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 1007 P/P 30 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-04-21 |
Estimated end date | Unknown |
Actual end date | 2023-06-08 |
Shortage status | Resolved |
Updated date | 2023-06-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-06-09 | English | Compare |
v4 | 2023-06-08 | French | Compare |
v3 | 2023-06-08 | English | Compare |
v2 | 2021-04-22 | French | Compare |
v1 | 2021-04-22 | English | Compare |
Showing 1 to 5 of 5